PMS2 and endometrial carcinoma: Combined deficiencies in MLH1 and PMS2 account for approximately half of MMRd endometrial carcinomas, the majority of which are caused by promoter hypermethylation of the MLH1 gene, with about 10% of cases caused by somatically acquired mutations [72,73].